IVUS Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study

ADAPT-DES was a large prospective multicenter registry that enrolled 8,583 patients undergoing drug-eluting stent (DES) implantation, comparing 1-year clinical outcomes between IVUS-guided and angiography-guided PCI procedures.

IVUS guidance was associated with significantly lower rates of stent thrombosis (0.6% vs 1.0%), myocardial infarction, and major adverse cardiac events at 1 year compared with angiography guidance alone. The benefit was particularly pronounced in complex lesions — bifurcations, long lesions, calcified arteries, left main disease — and in ACS presentations where accurate stent deployment is most critical.

IVUS guidance enables real-time optimization of stent sizing, landing zone selection, plaque characterization, and post-deployment confirmation of apposition and expansion — all of which reduce the risk of stent underexpansion and malapposition that drives stent thrombosis. Angiography provides only 2D luminal silhouette without information about plaque burden, vessel remodeling, or stent-wall contact.

The ADAPT-DES findings are corroborated by subsequent RCT evidence: the ULTIMATE trial (Zhang et al., 2018) randomized 1,448 all-comer patients and confirmed that IVUS-guided DES implantation significantly reduces target vessel failure compared with angiography guidance. IVUS-guided PCI is now recommended in European (Class I) and ACC/AHA (Class IIa) guidelines for complex coronary interventions.

We rate the evidence strong for observational data. A large prospective registry in 8,583 patients demonstrating that IVUS guidance significantly reduces stent thrombosis and MACE after DES implantation — substantive real-world evidence supporting IVUS guidance as the standard for complex PCI.